The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 28, 2010

Filed:

Sep. 16, 2004
Applicants:

Stefan Golz, Essen, DE;

Ulf Brüggemeier, Leichlingen, DE;

Bernhard Weingärtner, Wülfrath, DE;

Andreas Geerts, Wuppertal, DE;

Inventors:

Stefan Golz, Essen, DE;

Ulf Brüggemeier, Leichlingen, DE;

Bernhard Weingärtner, Wülfrath, DE;

Andreas Geerts, Wuppertal, DE;

Assignee:

Bayer Schering Pharma AG, Leverkusen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/10 (2006.01); C12N 9/00 (2006.01); C12N 15/00 (2006.01); C12N 1/20 (2006.01); C12N 1/00 (2006.01); C12P 19/34 (2006.01); C07H 21/04 (2006.01); A01N 43/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to a polynucleotide sequence of a novel acylglycerol acyltransferase-like protein MGAT-X1. The invention also provides the human MGAT-X1 associated with the dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases. The invention also provides assays for the identification of compounds useful for the modulation of dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases for treating of such diseases associated with expression of the MGAT-X1. The invention also features compounds which bind to and/or activate or inhibit the activity of MGAT-X1 as well as pharmaceutical compositions comprising such compounds.


Find Patent Forward Citations

Loading…